Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113


The extent of HLA-DR expression on HLA-DR(+) Tregs allows the identification of patients with clinically relevant borderline rejection.

Schaier M, Seissler N, Becker LE, Schaefer SM, Schmitt E, Meuer S, Hug F, Sommerer C, Waldherr R, Zeier M, Steinborn A.

Transpl Int. 2013 Mar;26(3):290-9. doi: 10.1111/tri.12032. Epub 2013 Jan 2.


DR(high+)CD45RA(-)-Tregs potentially affect the suppressive activity of the total Treg pool in renal transplant patients.

Schaier M, Seissler N, Schmitt E, Meuer S, Hug F, Zeier M, Steinborn A.

PLoS One. 2012;7(3):e34208. doi: 10.1371/journal.pone.0034208. Epub 2012 Mar 28.


Methylprednisolone treatment increases the proportion of the highly suppressive HLA-DR(+)-Treg-cells in transplanted patients.

Seissler N, Schmitt E, Hug F, Sommerer C, Zeier M, Schaier M, Steinborn A.

Transpl Immunol. 2012 Dec;27(4):157-61. doi: 10.1016/j.trim.2012.09.003. Epub 2012 Sep 26.


A distinct subset of HLA-DR+-regulatory T cells is involved in the induction of preterm labor during pregnancy and in the induction of organ rejection after transplantation.

Kisielewicz A, Schaier M, Schmitt E, Hug F, Haensch GM, Meuer S, Zeier M, Sohn C, Steinborn A.

Clin Immunol. 2010 Nov;137(2):209-20. doi: 10.1016/j.clim.2010.07.008. Epub 2010 Sep 6.


The success of assisted reproduction technologies in relation to composition of the total regulatory T cell (Treg) pool and different Treg subsets.

Schlossberger V, Schober L, Rehnitz J, Schaier M, Zeier M, Meuer S, Schmitt E, Toth B, Strowitzki T, Steinborn A.

Hum Reprod. 2013 Nov;28(11):3062-73. doi: 10.1093/humrep/det316. Epub 2013 Aug 6.


Term and preterm labor: decreased suppressive activity and changes in composition of the regulatory T-cell pool.

Schober L, Radnai D, Schmitt E, Mahnke K, Sohn C, Steinborn A.

Immunol Cell Biol. 2012 Nov;90(10):935-44. doi: 10.1038/icb.2012.33. Epub 2012 Jul 3.


Low circulating regulatory T-cell levels after acute rejection in liver transplantation.

Demirkiran A, Kok A, Kwekkeboom J, Kusters JG, Metselaar HJ, Tilanus HW, van der Laan LJ.

Liver Transpl. 2006 Feb;12(2):277-84.


Presence of FoxP3+ regulatory T Cells predicts outcome of subclinical rejection of renal allografts.

Bestard O, Cruzado JM, Rama I, Torras J, Gomà M, Serón D, Moreso F, Gil-Vernet S, Grinyó JM.

J Am Soc Nephrol. 2008 Oct;19(10):2020-6. doi: 10.1681/ASN.2007111174. Epub 2008 May 21.


Does borderline kidney allograft rejection always require treatment?

Németh D, Ovens J, Opelz G, Sommerer C, Döhler B, Becker LE, Gross ML, Waldherr R, Mieth M, Sadeghi M, Schmidt J, Langer RM, Zeier M, Süsal C.

Transplantation. 2010 Aug 27;90(4):427-32. doi: 10.1097/TP.0b013e3181e81b16.


Foxp3+ T cells in peripheral blood of renal transplant recipients and clinical correlations.

Lin WX, Christiansen D, Fu LL, Roberts MA, Sandrin MS, Ierino FL.

Nephrology (Carlton). 2012 May;17(4):415-22. doi: 10.1111/j.1440-1797.2012.01578.x.


Diagnostic and predictive value of an immunohistochemical profile in asymptomatic acute rejection of renal allografts.

Copin MC, Noel C, Hazzan M, Janin A, Pruvot FR, Dessaint JP, Lelievre G, Gosselin B.

Transpl Immunol. 1995 Sep;3(3):229-39.


Contribution of the expression of ICAM-1, HLA-DR and IL-2R to the diagnosis of acute rejection in renal allograft aspirative cytology.

Ribeiro-David DS, David-Neto E, Castro MC, Souza NA, Reis MM, Saldanha LB, Sabbaga E, Nahas WC, Ianhez IE.

Transpl Int. 1998;11 Suppl 1:S19-25.


Pretransplant low CD3+CD25high cell counts or a low CD3+CD25high/CD3+HLA-DR+ ratio are associated with an increased risk to acute renal allograft rejection.

Hueso M, Mestre M, Benavente Y, Bas J, Grinyó JM, Navarro E.

Transplantation. 2011 Sep 15;92(5):536-42. doi: 10.1097/TP.0b013e3182283c58.


CD20+ B-cell infiltration is related to the time after transplant and poor prognosis of acute cellular rejection in renal transplant.

Jiqiu W, Jinsong C, Dongrui C, Mingchao Z, Shuming J, Zhi-Hong L.

Exp Clin Transplant. 2013 Oct;11(5):412-7. doi: 10.6002/ect.2012.0143. Epub 2013 Feb 21.


HLA-DR expression on regulatory T cells is closely associated with the global immune activation in HIV-1 infected subjects naïve to antiretroviral therapy.

Xiao J, Qian KL, Cao QH, Qiu CL, Qiu C, Xue YL, Zhang XY, Zhong P, Xu JQ, Li MY, Wang Y.

Chin Med J (Engl). 2011 Aug;124(15):2340-6.


Expression patterns of HLA-DR+ or HLA-DR- on CD4+/CD25++/CD127low regulatory T cells in patients with allergy.

Geraldes L, Morgado J, Almeida A, Todo-Bom A, Santos P, Paiva A, Cheira C, Pais ML.

J Investig Allergol Clin Immunol. 2010;20(3):201-9.


Association of donor TNFRSF6 (FAS) gene polymorphism with acute rejection in renal transplant patients: a case-control study.

Cappellesso S, Valentin JF, Giraudeau B, Boulanger MD, Al-Najjar A, Büchler M, Halimi JM, Nivet H, Bardos P, Lebranchu Y, Watier H.

Nephrol Dial Transplant. 2004 Feb;19(2):439-43.


Absolute of CD4(+)CD25(+)FOXP3(+) regulatory T-cell count rather than its ratio in peripheral blood is related to long-term survival of renal allografts.

Liu L, Deng S, Teng L, Fu Q, Wang C, He X.

Transplant Proc. 2012 Jan;44(1):284-6. doi: 10.1016/j.transproceed.2011.12.014.


Severe immune dysregulation affects CD4⁺CD25(hi)FoxP3⁺ regulatory T cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive highly active antiretroviral therapy.

Méndez-Lagares G, Pozo-Balado MM, Genebat M, García Pergañeda A, Leal M, Pacheco YM.

J Infect Dis. 2012 May 15;205(10):1501-9. doi: 10.1093/infdis/jis230. Epub 2012 Mar 28. Erratum in: J Infect Dis. 2012 Dec 15;206(12):1951. del Mar del Pozo Balado, María [corrected to Pozo-Balado, María M]; Genebat González, Miguel [corrected to Genebat, Miguel]; García Pergañeda Sánchez, Antonio [corrected to García-Pergañeda, Antonio]; Leal Noval, Manuel [corrected to Leal, Manuel]; Pacheco López, Yolanda María [corrected to Pacheco, Yolanda María].


Achieving donor-specific hyporesponsiveness is associated with FOXP3+ regulatory T cell recruitment in human renal allograft infiltrates.

Bestard O, Cruzado JM, Mestre M, Caldés A, Bas J, Carrera M, Torras J, Rama I, Moreso F, Serón D, Grinyó JM.

J Immunol. 2007 Oct 1;179(7):4901-9.

Supplemental Content

Support Center